These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22690591)

  • 1. [Neuroprotection in epilepsy].
    Chepurnov SA; Suleĭmanova EM; Guliaev MV; Abbasova KR; Pirogov IuA; Chepurnova NE
    Usp Fiziol Nauk; 2012; 43(2):55-71. PubMed ID: 22690591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in neuroprotective strategies for preventing epilepsy.
    Acharya MM; Hattiangady B; Shetty AK
    Prog Neurobiol; 2008 Apr; 84(4):363-404. PubMed ID: 18207302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
    Polascheck N; Bankstahl M; Löscher W
    Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options.
    Pitkänen A; Immonen RJ; Gröhn OH; Kharatishvili I
    Epilepsia; 2009 Feb; 50 Suppl 2():21-9. PubMed ID: 19187291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis.
    Hernandez TD
    Trends Pharmacol Sci; 1997 Feb; 18(2):59-62. PubMed ID: 9090312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy.
    Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A
    Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia.
    Wan L; Cheng Y; Luo Z; Guo H; Zhao W; Gu Q; Yang X; Xu J; Bei W; Guo J
    J Ethnopharmacol; 2015 May; 165():118-26. PubMed ID: 25704930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection and epilepsy.
    Halász P; Rásonyi G
    Adv Exp Med Biol; 2004; 541():91-109. PubMed ID: 14977210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is animal experimentation telling us about new drug treatments of status epilepticus?
    Nehlig A
    Epilepsia; 2007; 48 Suppl 8():78-81. PubMed ID: 18330008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective agents and modulation of temporal lobe epilepsy.
    Fernandes MJ; Carneiro JE; Amorim RP; Araujo MG; Nehlig A
    Front Biosci (Elite Ed); 2015 Jan; 7(1):79-93. PubMed ID: 25553365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs in neuroprotection.
    Pitkänen A; Kubova H
    Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis.
    Diaz-Arrastia R; Agostini MA; Madden CJ; Van Ness PC
    Epilepsia; 2009 Feb; 50 Suppl 2():14-20. PubMed ID: 19187290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction. Posttraumatic epilepsy: treatable epileptogenesis.
    Jensen FE
    Epilepsia; 2009 Feb; 50 Suppl 2(Suppl 2):1-3. PubMed ID: 19187287
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial involvement in temporal lobe epilepsy.
    Kudin AP; Zsurka G; Elger CE; Kunz WS
    Exp Neurol; 2009 Aug; 218(2):326-32. PubMed ID: 19268667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy.
    Naegele JR
    Epilepsia; 2007; 48 Suppl 2():107-17. PubMed ID: 17571357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.
    Tchekalarova JD; Ivanova NM; Pechlivanova DM; Atanasova D; Lazarov N; Kortenska L; Mitreva R; Lozanov V; Stoynev A
    Pharmacol Biochem Behav; 2014 Dec; 127():27-36. PubMed ID: 25456349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of antiepileptic drugs.
    Trojnar MK; Małek R; Chrościńska M; Nowak S; Błaszczyk B; Czuczwar SJ
    Pol J Pharmacol; 2002; 54(6):557-66. PubMed ID: 12866709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: prospects of stem cell therapy for temporal lobe epilepsy.
    Shetty AK; Hattiangady B
    Stem Cells; 2007 Oct; 25(10):2396-407. PubMed ID: 17600108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.